Inside Precision Medicine June 14, 2024
IPM staff

An international study led by the Radboud University Medical Center has demonstrated that artificial intelligence (AI) can detect prostate cancer on MRI scans more effectively than radiologists, while also reducing false positives by half.

The findings, published in The Lancet Oncology, mark a significant advancement in the use of AI in medical diagnostics, particularly for prostate cancer.

The increasing routine use of MRI for men at higher risk of prostate cancer has placed a substantial burden on radiologists, who require sufficient expertise to accurately diagnose the disease. The shortage of experienced radiologists has further compounded this challenge. AI offers a promising solution to these issues by assisting in the diagnostic process.

The PI-CAI study, coordinated by AI expert Henkjan Huisman...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: AI (Artificial Intelligence), Provider, Radiology, Survey / Study, Technology, Trends
2024: record year for AI trials
2025: Provider organizations will embrace new AI and analytics techniques
AI and Automation in Healthcare – 2025 Health IT Predictions
Why The Public And Private Sectors Must Jointly Define Responsible AI
AI Crunches Clinical Notes to Highlight Care Improvement Opportunities

Share This Article